- Published Guideline
- Executive Summary
- Plain Language Summary
- Companion Article: Nonopioid, Multimodal Analgesia as First-line Therapy After Otolaryngology Operations: Primer on Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Slide deck available here. Contact the Research & Quality Team at firstname.lastname@example.org with any questions.
- Guideline Central Official Quick-Reference Pocket Guide and App
- Guideline Central Flipbook (FREE)
- Customizable Patient Handouts for Physicians: the handouts below are available as Adobe PDF files and may be customized with your office information or logo. Click here for instructions on how to customize these handouts.
- Education Opportunities
- AAO-HNSF OTO Logic visit www.otologic.org
- Annual Meeting Webcast: AAO-HNSF Clinical Practice Guideline Opioid Prescribing for Analgesia After Common Otolaryngology Operations
- Research Needs
Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations
This guideline was published in the April 2021 issue of Otolaryngology–Head and Neck Surgery.
Clinical Practice Guideline: Opioid Prescribing for Analgesia After Common Otolaryngology Operations published in Otolaryngology–Head and Neck Surgery on April 6. This clinical practice guideline (CPG) is intended for otolaryngologists who perform surgery and clinicians who manage pain after surgical procedures. The target patient for the CPG is any patient treated for anticipated or reported pain within the first 30 days after undergoing common otolaryngologic procedures. The purpose of this specialty-specific CPG is to provide evidence-informed recommendations on postoperative pain management of common otolaryngologic surgical procedures, with a focus on opioids. The CPG also allows identification of quality improvement opportunities. The goals of this guideline are to use the best available published scientific and/or clinical evidence to reduce the variation in care across the specialty and improve postoperative pain control while reducing risk of opioid use disorder.
Leadership: Samantha Anne, MD, MS (Chair), James "Whit" Mims, MD (Assistant-Chair), David E. Tunkel, MD (Methodologist), Richard M. Rosenfeld, MD, MPH, MBA (Methodologist).
Guideline Development Group: David S. Boisoneau, MD; Michael J. Brenner, MD; John D. Cramer, MD; David Dickerson, MD; Sandra A. Finestone, PsyD; Adam J. Folbe, MD, MS; Deepa J. Galaiya, MD; Anna H. Messner, MD; Allison Paisley, CRNP; Ahmad R. Sedaghat, MD, PhD; Kerstin M. Stenson, MD; Angela K. Sturm, MD; Erin M. Lambie, MS, MPH; Nui Dhepyasuwan, MEd; Taskin M. Monjur.
American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS)
American Broncho-Esophagological Association (ABEA)
American Head and Neck Society (AHNS)
American Neurotology Society (ANS)
American Otological Society (AOS)
American Rhinologic Society (ARS)
American Society of Pediatric Otolaryngology (ASPO)
Society of Otorhinolaryngology Head-Neck Nurses (SOHN)
The American Society of Anesthesiologists’ (ASA) Administrative Council has approved support of this CPG. Since the document has neither been presented to nor approved by either the ASA Board of Directors or House of Delegates, it is not an official or approved statement or policy of the Society. Variances from the recommendations contained in the document may be acceptable based on the judgment of the responsible anesthesiologist.